PT141 Bremelanotide 10mg * 10 Vials * 1 Kits

Description

Therapeutic Effects of PT 141 Bremelanotide * 10 Vials * 1 Kits Following MC 3 R or MC 4 R engagement, PT-141 has been characterized as triggering the standa.

PT141 Bremelanotide

How It Works

Research peptides are typically administered via subcutaneous injection after reconstitution with bacteriostatic water or sterile water for injection. The specific dosage, frequency, and cycle duration vary depending on the research protocol. Always follow standard laboratory safety protocols when handling research peptides.

Consult relevant scientific literature for specific administration guidelines. Use proper sterile technique and rotate injection sites as appropriate.

Product Specifications

• Contents: 10mg * 10 Vials * 1 Kits
• Appearance: Lyophilized powder
• Storage: 2-8??C (refrigerated)

How to Use & Administration

Research peptides are typically administered via subcutaneous injection after reconstitution with bacteriostatic water or sterile water for injection. The specific dosage, frequency, and cycle duration vary depending on the research protocol. Always follow standard laboratory safety protocols when handling research peptides.

Consult relevant scientific literature for specific administration guidelines. Use proper sterile technique and rotate injection sites as appropriate.

Safety & Research Considerations

Storage & Handling

Store lyophilized peptide powder in a cool, dry place at 2-8 degree C (refrigerate). After reconstitution with bacteriostatic water, keep refrigerated and use within the recommended timeframe. Protect from light and moisture. Do not freeze the reconstituted solution. Keep the product in its original packaging until ready for use.

Summary & Research Applications

Frequently Asked Questions

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. For laboratory research use only.